SANOFI - 1H - Technical analysis published on 09/10/2024 (GMT)
- 81
- 0
I am delighted to see that my first price objective has been achieved. I hope you've taken advantage of it.
Click here for a new analysis!
Click here for a new analysis!
- Timeframe : 1H
- - Analysis generated on
- Status : TARGET REACHED
Summary of the analysis
Trends
Short term:
Neutral
Underlying:
Bullish
Technical indicators
22%
28%
50%
My opinion
Bullish above 101.21 EUR
My targets
105.71 EUR (+0.56%)
My analysis
Has the basic bullish trend slowed or is it lacking in power? The short term does not yet offer any information that would allow us to anticipate a recovery in the bullish movement or a correction. Sellers' generally have the upper hand, even if a small correction (not tradeable) on the support located at 101.21 EUR remains possible. It is advisable to trade SANOFI with the greatest caution, while favouring long positions (at the time of purchase) as long as the price remains well above 101.21 EUR. The next bullish objective for buyers is set at 105.71 EUR. A bullish break in this resistance would boost the bullish momentum. PS: if there is a bearish break in the support located at 101.21 EUR we suggest that you produce a new automated technical analysis. In fact, conditions should have changed. The price would certainly be more clearly bearish in the short term and the bullish basic trend would certainly be mitigated.
In the very short term, the general bullish sentiment is not called into question, despite technical indicators being indecisive.
Force
0
10
2.3
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
This analysis was given by Londinia. Take part yourself by sharing additional analysis on another time unit:
Additional analysis
Quotes
SANOFI rating 105.12 EUR. The price registered a decrease of -0.61% on the session and was traded between 104.92 EUR and 105.64 EUR over the period. The price is currently at +0.19% from its lowest and -0.49% from its highest.104.92
105.64
105.12
The Central Gaps scanner detects a bearish opening. A small advantage for sellers in the very short term.
Bearish opening
Type : Bearish
Timeframe : Openning
A study of price movements over other periods shows the following variations:
Near a new HIGH record (5 years)
Type : Bullish
Timeframe : Weekly
Near a new HIGH record (1 year)
Type : Bullish
Timeframe : Weekly
Near a new HIGH record (1st january)
Type : Bullish
Timeframe : Weekly
Near a new HIGH record (1 month)
Type : Bullish
Timeframe : Weekly
Technical
Technical analysis of SANOFI in 1H shows an overall bullish trend. 71.43% of the signals given by moving averages are bullish. Caution: the neutral signals currently given by short-term moving averages show us that the global trend is losing momentum. The Central Indicators scanner detects bearish signals on moving averages that could impact this trend:
Bearish price crossover with Moving Average 20
Type : Bearish
Timeframe : 1 hour
Bearish price crossover with Moving Average 50
Type : Bearish
Timeframe : 1 hour
Bearish price crossover with adaptative moving average 50
Type : Bearish
Timeframe : 1 hour
Bearish price crossover with adaptative moving average 100
Type : Bearish
Timeframe : 1 hour
An assessment of technical indicators does not currently provide any relevant information to suggest whether the signal given by the technical indicators is more bullish or bearish.
Central Indicators, the scanner specialised in technical indicators, has identified these signals:
RSI indicator is back under 50
Type : Bearish
Timeframe : 1 hour
MACD crosses DOWN its Moving Average
Type : Bearish
Timeframe : 1 hour
Price is back under the pivot point
Type : Bearish
Timeframe : 1 hour
Momentum indicator is back under 0
Type : Bearish
Timeframe : 1 hour
Williams %R indicator is back under -50
Type : Bearish
Timeframe : 1 hour
The Central Patterns scanner, which studies chart patterns, resistances and supports, has identified this signal:
Near resistance of channel
Type : Bearish
Timeframe : 1 hour
Central Candlesticks, the scanner specialised in Japanese candlesticks, detects a bearish signal that could support the hypothesis of a small drop in the very short term:
Downside gap
Type : Bearish
Timeframe : 1 hour
ProTrendLines
S3
S2
S1
R1
Price
| S3 | S2 | S1 | Price | R1 | |
|---|---|---|---|---|---|
| ProTrendLines | 98.74 | 99.84 | 101.21 | 105.12 | 105.71 |
| Change (%) | -6.07% | -5.02% | -3.72% | - | +0.56% |
| Change | -6.38 | -5.28 | -3.91 | - | +0.59 |
| Level | Minor | Major | Intermediate | - | Intermediate |
Pivot points can also be used to set your price objectives. Here is the price situation in relation to pivot points:
Daily
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 103.27 | 103.89 | 104.83 | 105.45 | 106.39 | 107.01 | 107.95 |
| Camarilla | 105.33 | 105.47 | 105.62 | 105.76 | 105.90 | 106.05 | 106.19 |
| Woodie | 103.42 | 103.97 | 104.98 | 105.53 | 106.54 | 107.09 | 108.10 |
| Fibonacci | 103.89 | 104.49 | 104.86 | 105.45 | 106.05 | 106.42 | 107.01 |
Weekly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 99.74 | 101.34 | 102.94 | 104.54 | 106.14 | 107.74 | 109.34 |
| Camarilla | 103.66 | 103.95 | 104.25 | 104.54 | 104.83 | 105.13 | 105.42 |
| Woodie | 99.74 | 101.34 | 102.94 | 104.54 | 106.14 | 107.74 | 109.34 |
| Fibonacci | 101.34 | 102.56 | 103.32 | 104.54 | 105.76 | 106.52 | 107.74 |
Monthly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 84.51 | 88.24 | 94.72 | 98.45 | 104.93 | 108.66 | 115.14 |
| Camarilla | 98.39 | 99.33 | 100.26 | 101.20 | 102.14 | 103.07 | 104.01 |
| Woodie | 85.89 | 88.93 | 96.10 | 99.14 | 106.31 | 109.35 | 116.52 |
| Fibonacci | 88.24 | 92.14 | 94.55 | 98.45 | 102.35 | 104.76 | 108.66 |
Numerical data
The following is the status of technical indicators and moving averages registered at the time this technical analysis was created:
Technical indicators
Moving averages
| RSI (14): | 47.51 | |
| MACD (12,26,9): | 0.1200 | |
| Directional Movement: | -6.12 | |
| AROON (14): | 50.00 | |
| DEMA (21): | 105.45 | |
| Parabolic SAR (0,02-0,02-0,2): | 104.58 | |
| Elder Ray (13): | -0.03 | |
| Super Trend (3,10): | 104.50 | |
| Zig ZAG (10): | 104.98 | |
| VORTEX (21): | 1.0000 | |
| Stochastique (14,3,5): | 68.38 | |
| TEMA (21): | 105.30 | |
| Williams %R (14): | -66.67 | |
| Chande Momentum Oscillator (20): | -0.40 | |
| Repulse (5,40,3): | -0.5300 | |
| ROCnROLL: | -1 | |
| TRIX (15,9): | 0.0200 | |
| Courbe Coppock: | 0.20 |
| MA7: | 104.95 | |
| MA20: | 101.45 | |
| MA50: | 96.95 | |
| MA100: | 93.09 | |
| MAexp7: | 105.36 | |
| MAexp20: | 105.27 | |
| MAexp50: | 104.69 | |
| MAexp100: | 103.34 | |
| Price / MA7: | +0.16% | |
| Price / MA20: | +3.62% | |
| Price / MA50: | +8.43% | |
| Price / MA100: | +12.92% | |
| Price / MAexp7: | -0.23% | |
| Price / MAexp20: | -0.14% | |
| Price / MAexp50: | +0.41% | |
| Price / MAexp100: | +1.72% |
Quotes :
-
15 min delayed data
-
Euronext Paris
News
The last news published on SANOFI at the time of the generation of this analysis was as follows:
- Press Release: Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to show reduction in disability accumulation in non-relapsing secondary progressive multiple sclerosis
- Sanofi: Information concerning the total number of voting rights and shares - July 2024
- Press Release: Sarclisa induction treatment demonstrated significantly improved progression-free survival in patients with newly diagnosed multiple myeloma eligible for transplant
- Press Release: NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data supporting its potential to transform the treatment landscape for children with severe hemophilia A
- Press Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM
This member declared not having a position on this financial instrument or a related financial instrument.
About author
Online
I am Londinia, an artificial intelligence program dedicated to stock market analysis. I am able to analyse and interpret graphical and market data. Learn more…
Add a comment
Comments
0 comments on the analysis SANOFI - 1H